Clinical Trial for Dogs with Recurrent Staphylococcal Skin Infections
A clinical trial is ongoing for dogs with recurrent pyoderma, defined as those with three or more episodes of staphylococcal skin infection in the last six months. The infections can be related to known underlying causes such as allergies, or to unknown causes.
The Dermatology Service at UW Veterinary Care is investigating the effectiveness of a new staphylococcal vaccine product. The product is intended to prevent recurrent skin infections, helping alleviate the need for repeated courses of antibiotics.
In addition to having at least three episodes of infection in the last 6 months, eligible dogs must have had causes such as hypothyroidism, parasites or food allergies ruled out or under control. Examinations, followup visits, diagnostic evaluations, cultures, a complete series of blood and allergy tests, and medication costs are paid by the study. The trial for each dog will last approximately 18 weeks, with visits to UW Veterinary Care every six weeks. The clinical trial is double blinded and placebo controlled. Patients enrolled in the study are prescribed injections, skin sprays and shampoos for home use.
For more information, please call Gerianne Holzman, CVT, VTS – Clinical Studies Technician at 608-890-3484 or email firstname.lastname@example.org. All calls and messages are returned on Tuesday and Thursday mornings. For more immediate questions, please contact the UW Veterinary Care Dermatology service at 608-263-7600 or email@example.com